Brief Research Report
Accepted on 16 Feb 2026
IMPACT OF 1q VULNERABILITIES IN PATIENTS TREATED WITH ANTI-CD38 MONOCLONAL ANTIBODIES
in Hematologic Malignancies
Brief Research Report
Accepted on 16 Feb 2026
in Hematologic Malignancies
Original Research
Accepted on 16 Feb 2026
in Exercise Physiology
Study Protocol
Accepted on 16 Feb 2026
in Nuclear Medicine
Original Research
Accepted on 16 Feb 2026
in Plant Nutrition
Systematic Review
Accepted on 16 Feb 2026
in Neurocritical and Neurohospitalist Care
Community Case Study
Accepted on 16 Feb 2026
in Social Movements, Institutions and Governance
Review
Accepted on 16 Feb 2026
in Molecular Innate Immunity
Original Research
Accepted on 16 Feb 2026
in Inflammation
Original Research
Accepted on 16 Feb 2026
in Children and Health
Original Research
Accepted on 16 Feb 2026
in Alloimmunity and Transplantation
Case Report
Accepted on 16 Feb 2026
in Cardiovascular Surgery
Original Research
Accepted on 16 Feb 2026
in Educational Psychology
Original Research
Accepted on 16 Feb 2026
in Sustainable Design and Construction
Original Research
Accepted on 16 Feb 2026
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 16 Feb 2026
in Human Functioning Science: Classification, Measurement and Epidemiology of Functioning
Original Research
Accepted on 16 Feb 2026
in Cancer Immunity and Immunotherapy